Back to funds
View filing
ACORN CAPITAL ADVISORS, LLC
Updated 6 days agoManaged by Acorn Capital Advisors, Llc • Latest filing Q3 2026
Portfolio value
$364M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $295.1M |
| Q1 2026 | $351.8M |
| Q2 2026 | $366.5M |
| Q3 2026 | $364M |
Top holdings
22 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $80.2M | 1.13M | 22.04% | — | |
| 2 | $67M | 1.65M | 18.40% | — | |
| 3 | ? N/A PUMA BIOTECHNOLOGY INC | $41M | 4.13M | 11.27% | — |
| 4 | $36.5M | 3.50M | 10.03% | — | |
| 5 | $30.7M | 2.14M | 8.44% | — | |
| 6 | $18.9M | 1.54M | 5.20% | — | |
| 7 | $13.9M | 986.8K | 3.81% | — | |
| 8 | $12.4M | 668.4K | 3.42% | — | |
| 9 | $11.8M | 1.47M | 3.25% | — | |
| 10 | $7.8M | 2.84M | 2.13% | — | |
| 11 | $7.6M | 3.81M | 2.09% | — | |
| 12 | ? N/A AN2 THERAPEUTICS | $6.9M | 1.30M | 1.90% | — |
| 13 | $6.4M | 1.03M | 1.77% | — | |
| 14 | $5.3M | 1.75M | 1.47% | — | |
| 15 | $4.8M | 1.14M | 1.32% | — | |
| 16 | $4.1M | 1.14M | 1.12% | — | |
| 17 | $3.5M | 932.1K | 0.96% | — | |
| 18 | $1.8M | 216.2K | 0.49% | — | |
| 19 | $1.5M | 1.22M | 0.41% | — | |
| 20 | $834K | 1.44M | 0.23% | — |